Perrigo | PRGO - سرمایه عادی





سرمایه عادی تغییر دادن تاریخ
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 23.39B 2025-09
Bayer EUR 982.42M 0 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Corcept Therapeutics USD 105.97M 842K 2025-12
Dr.Reddys Laboratories INR 832.52M 144K 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
J&J USD 2.41B 1.74M 2025-12
Merck USD 2.49B 15.79M 2025-09
Nestle CHF 2.57B 42.99M 2025-12
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 1000K 2025-09
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 48.08M 47.52M 2025-09
Reckitt Benckiser GBP 679.21M 605.21M 2025-06
Sanofi EUR 1.21B 8.25M 2026-03
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Zoetis USD 424.93M 16.54M 2025-12